DADC
IBB icon

D.A. Davidson & Co’s iShares Biotechnology ETF IBB Stock Holding History

D.A. Davidson & Co’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Buy
6,402
+205
+3% +$35.2K 0.01% 903
2026
Q1 		$1.05M Buy
6,197
+448
+8% +$76.6K 0.01% 917
2025
Q4 		$970K Sell
5,749
-7,952
-58% -$1.29M 0.01% 905
2025
Q3 		$1.98M Buy
13,701
+8,825
+181% +$1.2M 0.01% 648
2025
Q2 		$617K Buy
4,876
+1,039
+27% +$128K ﹤0.01% 968
2025
Q1 		$491K Buy
3,837
+59
+2% +$8K ﹤0.01% 1027
2024
Q4 		$500K Buy
3,778
+118
+3% +$16.6K ﹤0.01% 1015
2024
Q3 		$533K Sell
3,660
-6,276
-63% -$908K ﹤0.01% 989
2024
Q2 		$1.36M Sell
9,936
-1,920
-16% -$256K 0.01% 640
2024
Q1 		$1.63M Buy
11,856
+6,943
+141% +$948K 0.01% 584
2023
Q4 		$667K Sell
4,913
-1,432
-23% -$175K 0.01% 841
2023
Q3 		$776K Sell
6,345
-1,176
-16% -$150K 0.01% 760
2023
Q2 		$955K Buy
7,521
+253
+3% +$32.9K 0.01% 707
2023
Q1 		$939K Sell
7,268
-15,447
-68% -$2.02M 0.01% 700
2022
Q4 		$2.98M Buy
22,715
+15,518
+216% +$2.01M 0.04% 356
2022
Q3 		$842K Sell
7,197
-14,037
-66% -$1.74M 0.01% 640
2022
Q2 		$2.5M Buy
21,234
+3,828
+22% +$454K 0.03% 374
2022
Q1 		$2.27M Buy
17,406
+1,244
+8% +$162K 0.02% 428
2021
Q4 		$2.47M Buy
16,162
+7,402
+84% +$1.15M 0.03% 416
2021
Q3 		$1.42M Buy
8,760
+55
+0.6% +$9.26K 0.02% 533
2021
Q2 		$1.43M Buy
8,705
+3,782
+77% +$583K 0.02% 531
2021
Q1 		$741K Buy
4,923
+1,316
+36% +$209K 0.01% 678
2020
Q4 		$546K Buy
3,607
+280
+8% +$40K 0.01% 679
2020
Q3 		$451K Sell
3,327
-34
-1% -$4.61K 0.01% 648
2020
Q2 		$459K Buy
3,361
+580
+21% +$73.9K 0.01% 622
2020
Q1 		$300K Buy
2,781
+28
+1% +$3.22K 0.01% 747
2019
Q4 		$332K Sell
2,753
-224
-8% -$25K 0.01% 787
2019
Q3 		$296K Buy
2,977
+1,052
+55% +$110K 0.01% 788
2019
Q2 		$210K Sell
1,925
-15
-0.8% -$1.6K ﹤0.01% 895
2019
Q1 		$214K Buy
+1,940
New +$213K ﹤0.01% 1021
2018
Q4 		– Sell
-1,777
Closed -$217K – 1128
2018
Q3 		$217K Sell
1,777
-203
-10% -$23.9K ﹤0.01% 1049
2018
Q2 		$218K Sell
1,980
-4,426
-69% -$473K ﹤0.01% 1004
2018
Q1 		$684K Sell
6,406
-1,405
-18% -$156K 0.01% 587
2017
Q4 		$834K Sell
7,811
-403
-5% -$43.1K 0.02% 509
2017
Q3 		$913K Buy
8,214
+5,796
+240% +$619K 0.02% 526
2017
Q2 		$249K Sell
2,418
-954
-28% -$94K 0.01% 869
2017
Q1 		$329K Buy
3,372
+471
+16% +$45.1K 0.01% 747
2016
Q4 		$256K Buy
2,901
+498
+21% +$45.3K 0.01% 894
2016
Q3 		$231K Buy
2,403
+312
+15% +$29.7K 0.01% 889
2016
Q2 		$179K Buy
2,091
+762
+57% +$68.4K 0.01% 881
2016
Q1 		$115K Buy
1,329
+204
+18% +$18.2K ﹤0.01% 1066
2015
Q4 		$126K Sell
1,125
-342
-23% -$37.1K ﹤0.01% 1028
2015
Q3 		$148K Buy
1,467
+9
+0.6% +$1.08K 0.01% 938
2015
Q2 		$179K Sell
1,458
-12,699
-90% -$1.52M 0.01% 913
2015
Q1 		$1.62M Sell
14,157
-489
-3% -$53.9K 0.05% 308
2014
Q4 		$1.48M Sell
14,646
-1,227
-8% -$119K 0.05% 326
2014
Q3 		$1.45M Sell
15,873
-1,050
-6% -$92.1K 0.05% 329
2014
Q2 		$1.45M Buy
16,923
+1,071
+7% +$84.4K 0.05% 341
2014
Q1 		$1.25M Sell
15,852
-3,291
-17% -$274K 0.04% 353
2013
Q4 		$1.45M Sell
19,143
-597
-3% -$42.4K 0.05% 302
2013
Q3 		$1.38M Sell
19,740
-3,720
-16% -$244K 0.06% 277
2013
Q2 		$1.36M Buy
+23,460
New +$1.36M 0.07% 270

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

D.A. Davidson & Co's IBB Position: Q2 2026 in Review

D.A. Davidson & Co increased its iShares Biotechnology ETF (IBB) stake by 3.3% in Q2 2026, buying an estimated $35.2K and bringing the position to 6,402 shares worth $1.22M. The position accounts for 0.01% of the portfolio, ranked #903.

D.A. Davidson & Co first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.98M in Q4 2022. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • D.A. Davidson & Co held 6,402 shares of iShares Biotechnology ETF worth $1.22M as of Q2 2026.
  • D.A. Davidson & Co bought 205 iShares Biotechnology ETF shares in Q2 2026, an estimated $35.2K.
  • iShares Biotechnology ETF made up 0.01% of D.A. Davidson & Co's portfolio in Q2 2026, its #903 holding.
  • D.A. Davidson & Co first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
  • D.A. Davidson & Co's iShares Biotechnology ETF position peaked at $2.98M in Q4 2022.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.